ARVINAS, INC. ARVN
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2018-09-27
ARVINAS, INC. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 6,258,808 | $166.6M | 8.83% |
| D. E. Shaw & Co., Inc. | 3,638,567 | $38.6M | 5.13% |
| TWO SIGMA INVESTMENTS, LP | 1,832,114 | $19.4M | 2.58% |
| CITADEL ADVISORS LLC | 1,227,488 | $13.0M | 1.73% |
| MILLENNIUM MANAGEMENT LLC | 576,352 | $6.1M | 0.81% |
| AQR CAPITAL MANAGEMENT LLC | 285,118 | $3.0M | 0.4% |
| Point72 Asset Management, L.P. | 229,807 | $2.4M | 0.32% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.